5
|
Racette SB, Park LK, Rashdi ST, Montgomery K, McKenzie KM, Deych E, Graham C, Das N, Fogarty TM, Van Zandt A, Carson T, Durbin D, Jonagan J, Rich MW, de las Fuentes L, Peterson LR. Benefits of the First Pritikin Outpatient Intensive Cardiac Rehabilitation Program. J Cardiopulm Rehabil Prev 2022; 42:449-455. [PMID: 35861951 PMCID: PMC9643589 DOI: 10.1097/hcr.0000000000000700] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
PURPOSE Intensive cardiac rehabilitation (ICR) is a comprehensive, medically supervised exercise treatment program covered by Medicare for patients with approved cardiac diagnoses. The aim of this study was to determine the benefits of the first Pritikin outpatient ICR program. METHODS This retrospective analysis included patients referred to ICR or traditional cardiac rehabilitation (CR) during the first 7 yr (2013-2019) at the first facility to implement Pritikin ICR. Intensive cardiac rehabilitation is composed of 36 education sessions on nutrition, exercise, and a healthy mindset, in addition to 36 monitored exercise sessions that comprise traditional CR. Assessments included anthropometrics (weight, body mass index, and waist circumference), dietary patterns, physical function (6-min walk test, [6MWT] Short Physical Performance Battery [SPPB: balance, 4-m walk, chair rise], handgrip strength), and health-related quality of life (Dartmouth COOP, 36-item Short Form Survey). Baseline and follow-up measures were compared within and between groups. RESULTS A total of 1963 patients enrolled (1507 ICR, 456 CR, 66.1 ± 11.4 yr, 68% male, 82% overweight or obese); 1141 completed the program (58%). The ICR patients completed 22 exercise and 18 education sessions in 9.6 wk; CR patients completed 19 exercise sessions in 10.3 wk. ICR resulted in improvements ( P < .001 pre vs post) in all anthropometric measures, dietary patterns, 6MWT distance, all SPPB components, grip strength, and health-related quality of life. The improvements in anthropometrics and dietary patterns were greater in ICR than in CR. CONCLUSIONS The Pritikin outpatient ICR program promoted improvements in several cardiovascular health indices. Critical next steps are to assess long-term health outcomes after ICR, including cardiac events and mortality.
Collapse
Affiliation(s)
- Susan B. Racette
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Lauren K. Park
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Serene T. Rashdi
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Kristin Montgomery
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Kristin M. McKenzie
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Elena Deych
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Christopher Graham
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Nikhil Das
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Taylor M. Fogarty
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Alexandria Van Zandt
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Tessa Carson
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Dotti Durbin
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Jennifer Jonagan
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Michael W. Rich
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Lisa de las Fuentes
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| | - Linda R. Peterson
- Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Park, Fogarty, and Van Zandt); Department of Medicine, Washington University School of Medicine, St Louis, Missouri (Drs Racette, Rich, de las Fuentes, and Peterson, Mss Rashdi, Montgomery, McKenzie, and Deych, and Mr Das); Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri (Mr Graham); and Barnes-Jewish Hospital, BJC HealthCare, St Louis, Missouri (Mss Carson, Durbin, and Jonagan)
| |
Collapse
|
6
|
Hama T, Ushijima A, Goto T, Nagamatsu H, Morita N, Yoshimachi F, Ikari Y, Kobayashi Y. Effect of Cardiac Rehabilitation on Glomerular Filtration Rate Using Serum Cystatin C Concentration in Patients With Cardiovascular Disease and Renal Dysfunction. J Cardiopulm Rehabil Prev 2022; 42:E15-E22. [PMID: 34793359 PMCID: PMC8884179 DOI: 10.1097/hcr.0000000000000651] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
PURPOSE Among patients with chronic kidney disease (CKD), little is known about whether the effect of cardiac rehabilitation (CR) on renal function differs across baseline estimated glomerular filtration rate using the serum concentration of cystatin C (eGFRcys). The aim of this study was to evaluate the effect of CR on renal function in patients with CKD. METHODS We performed a retrospective cohort study of patients with CKD (15 ≤ eGFRcys < 60 mL/min/1.73 m2) who participated in our CR program for cardiovascular disease. First, the patients were divided into three groups according to the baseline severity of the eGFRcys: G3a, G3b, and G4 groups. We compared the eGFRcys before and after the CR in each group. Second, to determine the association of baseline eGFRcys with the effect of CR, we fitted a linear regression model using the percent change in the eGFRcys (%ΔeGFRcys) as an outcome. RESULTS Of the 203 patients, 122 were in G3a, 60 were in G3b, and 21 were in G4 groups. The mean improvement of eGFRcys in each group was 1.3, 3.1, and 4.8 mL/min/1.73 m2, respectively. The %ΔeGFRcys was larger among patients with lower baseline eGFRcys (0.47% greater improvement of %ΔeGFRcys/one lower baseline eGFRcys; 95% CI, 0.23-0.72%). This association remained significant after adjustment for potential confounders (0.63% greater improvement of %ΔeGFRcys/one lower baseline eGFRcys; 95% CI, 0.35-0.91%). CONCLUSIONS The effect of CR on renal function was greater in patients with worse renal dysfunction measured by eGFRcys. A CR program could be useful for patients with severe renal dysfunction and it might have a beneficial effect on their renal function.
Collapse
Affiliation(s)
- Tomoaki Hama
- The Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan (Drs Hama, Ushijima, Nagamatsu, Morita, Yoshimachi, and Kobayashi); TXP Medical Co Ltd, Tokyo, and Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan (Dr Goto); and The Division of Cardiology, Department of Medicine, Tokai University Hospital, Shibuya City, Tokyo, Japan (Dr Ikari)
| | - Akiko Ushijima
- The Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan (Drs Hama, Ushijima, Nagamatsu, Morita, Yoshimachi, and Kobayashi); TXP Medical Co Ltd, Tokyo, and Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan (Dr Goto); and The Division of Cardiology, Department of Medicine, Tokai University Hospital, Shibuya City, Tokyo, Japan (Dr Ikari)
| | - Tadahiro Goto
- The Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan (Drs Hama, Ushijima, Nagamatsu, Morita, Yoshimachi, and Kobayashi); TXP Medical Co Ltd, Tokyo, and Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan (Dr Goto); and The Division of Cardiology, Department of Medicine, Tokai University Hospital, Shibuya City, Tokyo, Japan (Dr Ikari)
| | - Hirofumi Nagamatsu
- The Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan (Drs Hama, Ushijima, Nagamatsu, Morita, Yoshimachi, and Kobayashi); TXP Medical Co Ltd, Tokyo, and Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan (Dr Goto); and The Division of Cardiology, Department of Medicine, Tokai University Hospital, Shibuya City, Tokyo, Japan (Dr Ikari)
| | - Norishige Morita
- The Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan (Drs Hama, Ushijima, Nagamatsu, Morita, Yoshimachi, and Kobayashi); TXP Medical Co Ltd, Tokyo, and Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan (Dr Goto); and The Division of Cardiology, Department of Medicine, Tokai University Hospital, Shibuya City, Tokyo, Japan (Dr Ikari)
| | - Fuminobu Yoshimachi
- The Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan (Drs Hama, Ushijima, Nagamatsu, Morita, Yoshimachi, and Kobayashi); TXP Medical Co Ltd, Tokyo, and Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan (Dr Goto); and The Division of Cardiology, Department of Medicine, Tokai University Hospital, Shibuya City, Tokyo, Japan (Dr Ikari)
| | - Yuji Ikari
- The Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan (Drs Hama, Ushijima, Nagamatsu, Morita, Yoshimachi, and Kobayashi); TXP Medical Co Ltd, Tokyo, and Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan (Dr Goto); and The Division of Cardiology, Department of Medicine, Tokai University Hospital, Shibuya City, Tokyo, Japan (Dr Ikari)
| | - Yoshinori Kobayashi
- The Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan (Drs Hama, Ushijima, Nagamatsu, Morita, Yoshimachi, and Kobayashi); TXP Medical Co Ltd, Tokyo, and Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan (Dr Goto); and The Division of Cardiology, Department of Medicine, Tokai University Hospital, Shibuya City, Tokyo, Japan (Dr Ikari)
| |
Collapse
|